IncFact
Company Profiles: Revenue, Growth, Competition

MEDICAL & VACCINE PRODUCTS Revenue, Growth & Competitor Profile

Last updated:

Company Profile & Annual Report for Medical & Vaccine Products

Access the complete profile.

Medical & Vaccine Products Fast Facts

Revenue$10 - $100 million    See Exact Annual Revenue
Employees1 - 10Exact Company Size
Primary Industry4242 Drugs & Druggists' Sundries Merchant Wholesalers
Additional NAICS Codes42421
AddressMckesson Corporation
6555 State Highway 161
Irving, TX 75039

Note: Revenues for privately held companies are statistical evaluations.


Medical & Vaccine Products's annual revenues are $10-$50 million (see exact revenue data) and has 1-10 employees. It is classified as operating in the Drugs & Druggists' Sundries Merchant Wholesalers industry.


Medical & Vaccine Products's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Medical & Vaccine Products Annual Revenue and Growth Rate

Medical & Vaccine Products Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Medical & Vaccine Products's revenues are gauged from an analysis of company filings.



Medical & Vaccine Products's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Medical & Vaccine Products Revenue (Sales) Medical & Vaccine Products Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Recession Risk

Determine whether Medical & Vaccine Products grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Medical & Vaccine Products is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Drugs & Druggists' Sundries Merchant Wholesalers

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Medical & Vaccine Products's Largest Competitors

A competitive analysis shows these companies are in the same general field as Medical & Vaccine Products, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
AMERISOURCEBERGENConshohocken, PA100 
MCKESSONIrving, TX58 
CARDINAL HEALTH 414Dublin, OH42 
TAKEDA PHARMACEUTICALS AMERICALexington, MA31 
CATALENT PHARMA SOLUTIONSSomerset, NJ13 
OWENS & MINOR DISTRIBUTIONMechanicsville, VA11 
J M SMITHSpartanburg, SC3 
DAIICHI SANKYOBasking Ridge, NJ3 
HIKMA PHARMACEUTICALS USABerkeley Heights, NJ2 




Nearby Competitors

These companies are similar in business line and location to Medical & Vaccine Products. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
MCKESSONIrving, TX100 
PARAGON HEALTHCAREPlano, TX4 
BIOTE MEDICALIrving, TX1 
MEDICAL & VACCINE PRODUCTSIrving, TX0 




Future Competition: Medical & Vaccine Products's Fastest Growing Competitors

These companies are in the same general field as Medical & Vaccine Products and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Medical & Vaccine Products Competitors